Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ODX.L Share Price
  4. ODX.L Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksODX.L Regulatory News (ODX)

ODX.L Information
  • There is currently no data for ODX

Director/PDMR Shareholding

30 Jan 2012 11:57

RNS Number : 3889W
Omega Diagnostics Group PLC
30 January 2012
 



 

AIM:ODX

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Director/PDMR Shareholding

 

Omega, the AIM listed medical diagnostics company, announces that Kieron Harbinson, Group Finance Director of the Company, today purchased 90,000 Ordinary Shares of 4p each at a price of 11p. Following this transaction, Mr Harbinson's total holding is 294,150 Ordinary Shares, representing 0.35% of the total issued share capital of the Company.

 

 

Enquiries:

 

Omega Diagnostics Group plc

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

Seymour Pierce Group

Tel: 020 7107 8000

Freddy Crossley / Mark Percy (Corporate Finance)

www.seymourpierce.com

David Banks / Katie Ratner (Corporate Broking)

Walbrook PR Limited

Paul McManus

Tel: 020 7933 8787

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

 

Fiona Henson

Tel: 020 7933 8795

Mob: 07886 335 992

fiona.henson@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBBGDBLUXBGDG
45678910111213
Date   Source Headline
10th Apr 20187:00 amRNSStrategic Review of operations and Trading Update
12th Jan 201812:14 pmRNSHolding(s) in Company
21st Dec 20177:00 amRNSAllersys® CE-Mark
14th Dec 20177:01 amRNSCEO succession
14th Dec 20177:00 amRNSInterim results
29th Nov 20177:00 amRNSVISITECT® CD4 CE-Mark
1st Nov 20177:00 amRNSChange of Registered Office
23rd Oct 20177:00 amRNSTrading Update and Notice of Interim Results
18th Oct 20179:00 amRNSPDMR Participation in SAYE Scheme
16th Oct 20177:00 amRNSUS Supply Agreement
10th Oct 20177:00 amRNSHolding(s) in Company
5th Sep 20172:07 pmRNSExercise of Options and Total Voting Rights
29th Aug 201711:51 amRNSResult of AGM
18th Jul 201710:35 amRNSResult of General Meeting
6th Jul 201711:56 amRNSSale and leaseback of building owned by Omega GmbH
30th Jun 201712:13 pmRNSResult of Proposed Fundraising
30th Jun 20177:01 amRNSProposed Fundraising
30th Jun 20177:00 amRNSFinal Results
25th Apr 20177:00 amRNSTrading Update and Notice of Results
21st Apr 201712:41 pmRNSHolding(s) in Company
29th Mar 20177:00 amRNSVISITECT® Malaria CE-Mark & Indian FDA inspection
7th Mar 20178:45 amRNSHolding(s) in Company
27th Feb 201712:52 pmRNSHolding(s) in Company
27th Jan 20177:00 amRNSUpdate on discussions with IDS
11th Jan 20177:00 amRNSISO accreditation for manufacturing facility
29th Nov 20167:15 amRNSHardman Research: Food intolerance driving growth
24th Nov 20167:52 amRNSHolding(s) in Company
21st Nov 20167:00 amRNSHalf-year Report
31st Oct 20167:15 amRNSHardman Research: Diagnosing growth opportunities
17th Oct 20167:00 amRNSTrading Update and Notice of Interim Results
10th Aug 201612:22 pmRNSResult of AGM
2nd Aug 20167:00 amRNSR&D Grant Funding
4th Jul 20168:18 amRNSHolding(s) in Company
1st Jul 201611:48 amRNSHolding(s) in Company
27th Jun 20167:00 amRNSFinal Results
9th Jun 20169:07 amRNSHolding(s) in Company
21st Apr 20167:00 amRNSTrading Update & Notice of Results
8th Feb 20168:22 amRNSHolding(s) in Company
4th Dec 20154:25 pmRNSHolding(s) in Company
3rd Dec 201512:28 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSHalf Yearly Report
26th Oct 20157:00 amRNSTrading Update and Notice of Interim Results
30th Sep 20159:07 amRNSGrant of Options
7th Sep 20151:21 pmRNSResult of AGM
7th Jul 20157:00 amRNSFinal Results
5th Jun 201510:01 amRNSHolding(s) in Company
1st Jun 20157:00 amRNSDevelopment Update - Visitect® CD4 and Allergy
27th Apr 20157:00 amRNSBoard Appointment
15th Apr 20157:00 amRNSTrading update and Notice of Results
1st Dec 201410:37 amRNSDirector/PDMR Shareholding
45678910111213

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
GLDA
Amundi Physical Gold ETC (C)
LSE
-2.33%
SUMO
SUMO.L
LSE
0.00%
AVCT
Avacta Group
LSE
2.14%
WKP
Workspace
LSE
-1.12%
PAC
Pacific Assets Trust
LSE
-0.47%
Trending
BEM
Beowulf Mining PLC
LSE
63.64%
LLOY
Lloyds
LSE
-1.33%
NANO
Nanoco
LSE
-10.69%
HPOW
H-power
LSE
-3.96%
IMM
Immupharma
LSE
-2.26%